These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2743277)
1. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method. Hölting T; Schlag P; Steinbächer M; Kretzschmar U; Georgi P; Herfarth C Cancer; 1989 Aug; 64(4):830-3. PubMed ID: 2743277 [TBL] [Abstract][Full Text] [Related]
2. [Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?]. Hölting T; Steinbächer M; Kretzschmar U; Georgi P; Schlag P Onkologie; 1989 Aug; 12 Suppl 1():20-5. PubMed ID: 2685691 [TBL] [Abstract][Full Text] [Related]
3. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences. Hölting T; Schlag P; Georgi P Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223 [TBL] [Abstract][Full Text] [Related]
4. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871 [TBL] [Abstract][Full Text] [Related]
5. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study]. Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155 [TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193 [TBL] [Abstract][Full Text] [Related]
7. [Current role of immunoscintigraphy for surgical therapy of the recurrence of colorectal cancers]. Schlag P; Hölting T; Steinbächer M; Kretzschmar U; Georgi P Chirurg; 1987 Sep; 58(9):594-6. PubMed ID: 3677890 [TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments. Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454 [TBL] [Abstract][Full Text] [Related]
9. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer]. Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab')2. Aprile C; Prati U; Saponaro R; Roveda L; Carena M; Gastaldo L Int J Rad Appl Instrum B; 1991; 18(1):51-2. PubMed ID: 2010306 [TBL] [Abstract][Full Text] [Related]
13. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58. Yao YF; Yang Z; Li ZF; Gu J World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478 [TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA. Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552 [TBL] [Abstract][Full Text] [Related]
15. The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Baulieu F; Bourlier P; Scotto B; Mor C; Eder V; Picon L; De Calan L; Dorval E; Pottier JM; Baulieu JL Nucl Med Commun; 2001 Dec; 22(12):1295-304. PubMed ID: 11711899 [TBL] [Abstract][Full Text] [Related]
16. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784 [TBL] [Abstract][Full Text] [Related]
17. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995 [TBL] [Abstract][Full Text] [Related]
18. [Immunoscintigraphy with monoclonal antibody Tc99m BW 431/26 in the diagnosis of colorectal carcinoma]. Muxí A; Bassa P; Moragas M; Fernández R; Pons F; Setoaín J Med Clin (Barc); 1991 Mar; 96(8):287-91. PubMed ID: 2041400 [TBL] [Abstract][Full Text] [Related]
19. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist]. Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823 [TBL] [Abstract][Full Text] [Related]
20. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125. Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]